Insightful Analysis: Trends, Share, Growth Prospects, and Forecast for the NGS-based RNA-seq Market through 2027
The Global NGS-based RNA-seq Market by Product & Services (Sample Preparation, Platforms & Consumables, Services, Data Analysis), Technology (SBS, SMRT, Nanopore), Application (De Novo, Epigenetics, small RNA), End-User, Region – Global Forecast to 2027″, is projected to reach USD 5.5 billion by 2027 from USD 2.5 billion in 2022, at a CAGR of 17.2% during the forecast...
Insightful Analysis: Trends, Share, Growth Prospects, and Forecast for the NGS-based RNA-seq Market through 2027
The Global NGS-based RNA-seq Market by Product & Services (Sample Preparation, Platforms & Consumables, Services, Data Analysis), Technology (SBS, SMRT, Nanopore), Application (De Novo, Epigenetics, small RNA), End-User, Region – Global Forecast to 2027″, is projected to reach USD 5.5 billion by 2027 from USD 2.5 billion in 2022, at a CAGR of 17.2% during the forecast...
NGS-based RNA-seq Market Projected to Reach $ 5.5 Billion by 2027: Global Trends, Business Strategies, and Updated Research
The Global NGS-based RNA-seq Market experienced substantial growth, with its revenue estimated at $2.5 billion in 2022 and projected to reach $5.5 billion by 2027, showcasing a remarkable CAGR of 17.2% during the period from 2022 to 2027. A comprehensive new research study has been conducted, encompassing various facets of the market, including industry trends, pricing analysis, patent evaluation,...
NGS-based RNA-seq Market Trends, Business Insights And Forecast to 2027
The Global NGS-based RNA-seq Market in terms of revenue was estimated to be worth $2.5 billion in 2022 and is poised to reach $5.5 billion by 2027, growing at a CAGR of 17.2% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials,...
NGS-based RNA-seq Market Benefits, Growth, Demands, Trends and Applications by 2027
The Global NGS-based RNA-seq Market by Product & Services (Sample Preparation, Platforms & Consumables, Services, Data Analysis), Technology (SBS, SMRT, Nanopore), Application (De Novo, Epigenetics, small RNA), End-User, Region – Global Forecast to 2027″, is projected to reach USD 5.5 billion by 2027 from USD 2.5 billion in 2022, at a CAGR of 17.2% during the forecast...
NGS-based RNA-seq Market Report Future Development, Top Key Players, Share, Size and Forecast To 2027
The Global NGS-based RNA-seq Market is projected to reach USD 5.5 billion by 2027 from USD 2.5 billion in 2022, at a CAGR of 17.2% during the forecast period. Factors such as the advantages of RNA sequencing over conventional technologies, the decreasing costs of genome sequencing, increasing government funding to support genomics projects, growing research involving RNA sequencing, growing...
NGS-based RNA-seq Market 2022 | Growth, Demands, Trends, Career Opportunities and Forecast to 2024
NGS-based RNA-seq Marketsize is projected to reach USD 4.2 billion by 2024 from USD 1.7 billion in 2019, at a CAGR of 20.0%. Advantages of RNA-seq over conventional technologies, increasing number of RNA-seq grants, growing number of research activities involving RNA-seq, and rapid growth in precision medicine are the key factors driving the growth of the NGS-based RNA-sequencing market.
Download...
NGS-based RNA-seq Market worth $ 4.2 billion by 2024 – Exclusive Report by MarketsandMarkets™
NGS-based RNA-seq Market by Product & Services (Sample Preparation, Platforms & Consumables, Services, Data Analysis), Technology (SBS, SMRT, Nanopore), Application (De Novo, Epigenetics, small RNA), End-User, Region – Global Forecast to 2024″ The NGS-based RNA-sequencing market size is projected to reach USD 4.2 billion by 2024 from USD 1.7 billion in 2019, at a...
NGS-Based RNA-Sequencing Market to Register Substantial Expansion by 2024
The NGS-based
RNA-sequencing market size is projected to reach USD 4.2 billion by 2024
from USD 1.7 billion in 2019, at a CAGR of 20.0%. An increasing number of
RNA-seq grants, advantages of RNA-seq over conventional technologies, rapid
growth in precision medicine market clubbed with a growing number of research
activities involving RNA-seq are the key factors driving the growth of...